Australia's most trusted
source of pharma news
Wednesday, 04 June 2025
Wednesday, 4 June 2025
Subscribe
Login
News Headlines
News Headlines
News
New ADC plus Covid drug ticked
Posted 26 May 2025 AM
AstraZeneca has scored approval for its anti-Trop2 antibody drug-conjugate (ADC) Datroway along with its latest Covid offering Kavigale, a long-acting antibody intended to safeguard immunocompromised individuals.
Datroway, also known as datopotamab deruxtecan, is the second ADC to emerge from AstraZeneca and Daiichi Sankyo’s partnership, following Enhertu.
To see the whole article, please login
Posted 26 May 2025 AM
AstraZeneca has scored approval for its anti-Trop2 antibody drug-conjugate (ADC) Datroway along with its latest Covid offering Kavigale, a long-acting antibody intended to safeguard immunocompromised individuals.
Datroway, also known as datopotamab deruxtecan, is the second ADC to emerge from AstraZeneca and Daiichi Sankyo’s partnership, following Enhertu.
To see the whole article, please login
Popular
Latest Jobs
Pharma in Focus Jobs
Marketing & Communications (3)
- Operations/Production Planner - Parkville
- Data Analyst - Clinical Trials - Kensington
- CRM & Digital Marketing Specialist - Sydney
Sales & Customer Relations (18)
- Medical Representative - Melbourne
- Customer Care Representative - Macquarie Park
- Customer Service Team Leader - East Ryde
- Customer Service Representative - Belrose
- Senior Customer Service Administrator - Belrose
- Medical Representative - Melbourne
- State Account Manager - Perth
- Hospital Specialist Representative - Sunshine Coast
- Pharmacy Sales Representative - Queensland
- Hospital Specialist Representative - Brisbane
- Medical Devices Territory Manager - Brisbane
- Customer Service Representative - Belrose
- Pharmaceutical Sales Representative - Sydney
- Medical Representative - Melbourne
- Medical Sales Representative - Canberra
- Customer Service Representative - Pemulwuy
- Account Manager - Sydney
- Account Manager - Newcastle
Clinical & Medical, R&D (15)
- Medical Representative - Melbourne
- Medical Science Liaison - Victoria
- Medical Science Liaison - Cardiometabolic (12-month Contract) - Melbourne
- Quality Control Analytical Technology Scientist - Broadmeadows
- Clinical Trials Pharmacy Manager - Melbourne
- Senior Scientist - Diagnostics - Clayton
- Medical Representative - Melbourne
- Clinical Trial Investigator - Camberwell
- Data Analyst - Clinical Trials - Kensington
- Medical Devices Territory Manager - Brisbane
- Medical Science Liaison - Victoria
- Medical Representative - Melbourne
- Medical Sales Representative - Canberra
- Scientific Technician - Melbourne
- Clinical Site Director - Wollongong
Regulatory, Pharmacovigilance & QA (4)
- Quality Control Analytical Technology Scientist - Broadmeadows
- Regulatory Affairs Associate - Lane Cove NSW
- Quality Systems Specialist - Brisbane
- Senior Pharmacovigilance Associate - Sydney
Devices (1)
Other (22)
- Warehouse Assistant - North Ryde
- Senior Recruitment Consultant - Sydney
- Category Specialist - North Ryde
- Director of Cloud Engineering - Brisbane
- Talent Acquisition Coordinator - Macquarie Park
- People and Culture Coordinator - Macquarie Park
- Inventory Controller - Belrose
- Category Manager - Direct s - North Ryde
- Digital Marketer - Sydney
- Business Analyst - St Leonards
- Logistics & Warehouse Coordinator - Alexandria
- ERP Business Partner - Macquarie Park
- GP Rep Brisbane North - Brisbane
- Service Coordinator - Belrose
- Sterility Assurance Specialist - 36064 - Broadmeadows
- Senior Recruitment Consultant - Sydney
- Recruitment Consultant - Sydney
- Service Coordinator - Belrose
- Customer Operations Specialist - Planned Services - Macquarie Park
- Service Coordinator - Belrose
- Recruitment Consultant - Sydney
- Drug Safety Controller - Melbourne
MORE NEWS
Email this article to a friend
From:
Print this article
Copyright Notice
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.